Drug executives face prison for role in opioid crisis

Thursday, several executives at Insys Therapeutics were sentenced to prison for a bribery scheme that paid doctors to prescribe the company’s lucrative and addictive painkiller. These sentences are a landmark moment in the push to hold drug makers accountable for their role in America’s deadly opioid epidemic. William Brangham reports, in a collaboration with Frontline and the Financial Times.